https://www.selleckchem.com/pr....oducts/tacrine-hcl.h
The best therapeutic approach for local relapses of previously irradiated prostate cancer (PC) is still not defined. Re-irradiation (Re-I) could offer a chance of cure for highly selected patients, although high quality evidences are lacking. The aim of our study is to provide a literature review on efficacy and safety of Re-I. Only studies where Re-I field overlaps with previous radiotherapy were considered. To determine 2 and 4years overall mortality (OM), 2 and 4years biochemical failure (BF) and pooled acute and late G≥3 toxicit
Like
Comment
Share
